The Goldman Sachs Group Cuts BILL (NYSE:BILL) Price Target to $44.00

BILL (NYSE:BILLFree Report) had its price objective lowered by The Goldman Sachs Group from $52.00 to $44.00 in a research note released on Monday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other analysts have also recently commented on BILL. Keefe, Bruyette & Woods decreased their price target on shares of BILL from $60.00 to $49.00 and set a “market perform” rating on the stock in a research note on Friday, February 6th. Citigroup decreased their price target on shares of BILL from $71.00 to $62.00 and set a “buy” rating on the stock in a research note on Thursday, January 22nd. Canaccord Genuity Group raised their price objective on shares of BILL from $75.00 to $77.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th. BMO Capital Markets reduced their price objective on shares of BILL from $50.00 to $46.00 and set a “market perform” rating on the stock in a research note on Friday, February 6th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $75.00 price objective on shares of BILL in a research note on Friday, February 6th. Thirteen research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, BILL presently has an average rating of “Hold” and an average target price of $56.59.

Check Out Our Latest Research Report on BILL

BILL Price Performance

BILL opened at $39.31 on Monday. BILL has a one year low of $34.44 and a one year high of $57.21. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.65. The company’s 50 day simple moving average is $41.69 and its 200-day simple moving average is $47.49. The stock has a market capitalization of $3.89 billion, a P/E ratio of -163.81, a price-to-earnings-growth ratio of 4.35 and a beta of 1.32.

BILL (NYSE:BILLGet Free Report) last released its quarterly earnings results on Thursday, February 5th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.56 by $0.08. BILL had a negative net margin of 1.56% and a positive return on equity of 1.70%. The business had revenue of $414.67 million for the quarter, compared to analysts’ expectations of $399.71 million. During the same period in the prior year, the firm earned $0.56 earnings per share. BILL’s revenue was up 14.4% compared to the same quarter last year. BILL has set its Q3 2026 guidance at 0.530-0.570 EPS and its FY 2026 guidance at 2.330-2.410 EPS. Sell-side analysts anticipate that BILL will post 0.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On BILL

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of BILL by 3.5% during the third quarter. Vanguard Group Inc. now owns 10,843,612 shares of the company’s stock worth $574,386,000 after purchasing an additional 371,265 shares in the last quarter. ER Collective Holdings LLC bought a new position in shares of BILL during the fourth quarter worth $464,588,000. Contour Asset Management LLC boosted its position in shares of BILL by 45.5% during the fourth quarter. Contour Asset Management LLC now owns 4,710,570 shares of the company’s stock worth $256,914,000 after purchasing an additional 1,472,132 shares in the last quarter. Marshall Wace LLP boosted its position in shares of BILL by 36.5% during the fourth quarter. Marshall Wace LLP now owns 2,958,096 shares of the company’s stock worth $161,335,000 after purchasing an additional 791,197 shares in the last quarter. Finally, Senvest Management LLC boosted its position in shares of BILL by 155.8% during the fourth quarter. Senvest Management LLC now owns 2,573,261 shares of the company’s stock worth $140,346,000 after purchasing an additional 1,567,186 shares in the last quarter. 97.99% of the stock is owned by institutional investors.

Trending Headlines about BILL

Here are the key news stories impacting BILL this week:

  • Positive Sentiment: Recent company fundamentals: BILL reported a quarterly EPS and revenue beat and provided FY/Q3 2026 guidance, which supports the stock’s strength as investors focus on improving growth and profitability metrics.
  • Neutral Sentiment: Trump signed a bill reauthorizing federal aid to defense startups — largely sector/policy news with limited direct relevance to BILL’s payments/fintech business. Article Title
  • Neutral Sentiment: Various state and federal legislative items (housing law in Indiana, Tennessee healthcare tracking bill, Michigan voter-registration bill, bills on aviation safety and driver education) are part of the daily policy backdrop but are unlikely to move BILL shares materially. Examples: Article Title and Article Title
  • Neutral Sentiment: Other state-level bills (Ohio on AI-generated CSAM, Tennessee music board, California immigrant services protections, and various local measures) are politically noteworthy but not directly tied to BILL’s operations. Article Title
  • Negative Sentiment: Analyst pressure: The Goldman Sachs note forecasting a pessimistic outlook for BILL could weigh on sentiment and create downside risk if other investors follow the call; this helps explain some intraday volatility. Article Title

About BILL

(Get Free Report)

BILL Holdings, Inc provides financial automation software for small and midsize businesses worldwide. The company provides software-as-a-service, cloud-based payments, and spend management products, which allow users to automate accounts payable and accounts receivable transactions, as well as enable users to connect with their suppliers and/or customers to do business, eliminate expense reports, manage cash flows, and improve office efficiency. It also offers onboarding implementation support, and ongoing support and training services.

Recommended Stories

Analyst Recommendations for BILL (NYSE:BILL)

Receive News & Ratings for BILL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BILL and related companies with MarketBeat.com's FREE daily email newsletter.